TY - JOUR
T1 - Central vagal activation by alpha2-adrenergic stimulation is impaired in spontaneously hypertensive rats
AU - Kawada, T.
AU - Akiyama, T.
AU - Shimizu, S.
AU - Kamiya, A.
AU - Uemura, K.
AU - Sata, Y.
AU - Shirai, M.
AU - Sugimachi, M.
PY - 2012/9
Y1 - 2012/9
N2 - Aim: To elucidate the abnormality of vagal control in spontaneously hypertensive rats (SHR) by measuring left ventricular myocardial interstitial acetylcholine (ACh) release in response to α2-adrenergic stimulation as an index of in vivo vagal nerve activity. Methods: A cardiac microdialysis technique was applied to the rat left ventricle in vivo, and the effect of α2-adrenergic stimulation by medetomidine or electrical vagal nerve stimulation on myocardial interstitial ACh levels was examined in normotensive Wistar-Kyoto rats (WKY) and SHR under anaesthetized conditions. Results: Intravenous medetomidine (0.1 mg kg-1) significantly increased the ACh levels in WKY (from 2.4 ± 0.6 to 4.2 ± 1.3 nmol L-1, P < 0.05, n = 7) but not in SHR (from 2.5 ± 0.7 to 2.7 ± 0.7 nmol L-1, n = 7). In contrast, electrical vagal nerve stimulation increased the ACh levels in both WKY (from 1.0 ± 0.4 to 2.9 ± 0.9 nmol L-1, P < 0.001, n = 6) and SHR (from 0.9 ± 0.2 to 2.2 ± 0.4 nmol L-1, P < 0.001, n = 6). Intravenous administration of medetomidine (0.1 mg kg-1) did not affect the vagal nerve stimulation-induced ACh release in either WKY or SHR. Conclusion: Medetomidine-induced central vagal activation was impaired in SHR, whereas peripheral vagal control of ACh release was preserved. In addition to abnormal sympathetic control, vagal control by the central nervous system may be impaired in SHR.
AB - Aim: To elucidate the abnormality of vagal control in spontaneously hypertensive rats (SHR) by measuring left ventricular myocardial interstitial acetylcholine (ACh) release in response to α2-adrenergic stimulation as an index of in vivo vagal nerve activity. Methods: A cardiac microdialysis technique was applied to the rat left ventricle in vivo, and the effect of α2-adrenergic stimulation by medetomidine or electrical vagal nerve stimulation on myocardial interstitial ACh levels was examined in normotensive Wistar-Kyoto rats (WKY) and SHR under anaesthetized conditions. Results: Intravenous medetomidine (0.1 mg kg-1) significantly increased the ACh levels in WKY (from 2.4 ± 0.6 to 4.2 ± 1.3 nmol L-1, P < 0.05, n = 7) but not in SHR (from 2.5 ± 0.7 to 2.7 ± 0.7 nmol L-1, n = 7). In contrast, electrical vagal nerve stimulation increased the ACh levels in both WKY (from 1.0 ± 0.4 to 2.9 ± 0.9 nmol L-1, P < 0.001, n = 6) and SHR (from 0.9 ± 0.2 to 2.2 ± 0.4 nmol L-1, P < 0.001, n = 6). Intravenous administration of medetomidine (0.1 mg kg-1) did not affect the vagal nerve stimulation-induced ACh release in either WKY or SHR. Conclusion: Medetomidine-induced central vagal activation was impaired in SHR, whereas peripheral vagal control of ACh release was preserved. In addition to abnormal sympathetic control, vagal control by the central nervous system may be impaired in SHR.
KW - Acetylcholine
KW - Cardiac microdialysis
KW - Medetomidine
KW - Rats
KW - Vagal nerve stimulation
UR - http://www.scopus.com/inward/record.url?scp=84864501846&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84864501846&partnerID=8YFLogxK
U2 - 10.1111/j.1748-1716.2012.02439.x
DO - 10.1111/j.1748-1716.2012.02439.x
M3 - Article
C2 - 22463699
AN - SCOPUS:84864501846
VL - 206
SP - 72
EP - 79
JO - Acta Physiologica
JF - Acta Physiologica
SN - 1748-1708
IS - 1
ER -